You can buy or sell Verastem and other stocks, options, ETFs, and crypto commission-free!
Verastem, Inc. Common Stock, also called Verastem, is a biopharmaceutical company focusing on developing and commercializing medicines to improve the survival and quality of life of cancer patients. Read More It markets COPIKTRA™ (duvelisib), an oral inhibitor of phosphoinositide 3-kinase (PI3K) and dual inhibitor of PI3K-delta and PI3K-gamma, which is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma after at least two prior therapies and relapsed or refractory follicular lymphoma (FL) after at least two prior systemic therapies. The indication in FL is approved under accelerated approval based on overall response rate. In addition, it is developing the focal adhesion kinase inhibitor defactinib, which is being evaluated in three separate clinical collaborations in combination with immunotherapeutic agents for the treatment of various different cancer types, including pancreatic cancer, ovarian cancer, non-small cell lung cancer (NSCLC), and mesothelioma. Verastem, Inc. has collaboration agreements with Yakult Honsha Co., Ltd., CSPS Pharmaceutical Group Limited and The Leukemia & Lymphoma Society. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
52 Week High
52 Week Low
The Motley FoolMar 14
3 Penny Stocks That Could Make You Rich -- or Regretful
Penny stocks -- or stocks with sub-$5 share prices -- can be tremendous growth vehicles for risk-tolerant investors. By the same token, stocks that trade at these bargain-basement levels often do so for a very good reason, such as large outstanding share counts, poor underlying fundamentals, or recent strategic setbacks. The penny biotech stocks Inovio (NASDAQ:INO), Geron (NASDAQ:GERN), and Verastem (NASDAQ:VSTM) each suffer from one or more of these core problems. Nevertheless, these three companies also ...
Verastem Inc. Stock Quote (U.S.: Nasdaq)
Verastem Inc. Verastem, Inc. is a commercial-stage company focused on the discovery, development, and commercialization of drugs to aid patients suffering from cancer. Its product candidates include COPIKTR (duvelisib), a treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma after at least two prior therapies and relapsed or refractory follicular lymphoma after at least two prior systemic therapies. Its pipeline candidate defactinib, is a focal a...
The Motley FoolMar 13
Verastem (VSTM) Q4 2018 Earnings Conference Call Transcript
Verastem (NASDAQ:VSTM) Q4 2018 Earnings Conference Call March 12, 2019 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good afternoon and welcome to the Verastem Oncology investor conference call on Tuesday, March 12, 2019. [Operator instructions] Please be advised that this call is being recorded as a company's request and will be available on the company's website for a period of 90 days from today. At this time, I would like to introduce...
-$0.53 per share
-$0.37 per share